AbbVie ABBV Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.39B+81.5% | $5.23B-5.3% | $5.63B-22.4% | $6.47B-50.7% | $5.18B-71.4% | ||
| $12.48B0.0% | $12.59B+15.3% | $12.77B+11.3% | $12.64B+7.8% | $12.48B+4.4% | ||
| $5.05B+11.6% | $4.95B+18.4% | $4.94B+11.0% | $4.96B+17.6% | $4.53B+6.6% | ||
| $33.53B+21.2% | $29.06B+13.6% | $28.54B+2.7% | $29.26B-13.5% | $27.68B-28.8% | ||
| $5.69B+8.6% | $5.63B+9.6% | $5.48B+6.7% | $5.28B+5.2% | $5.24B+5.2% | ||
| $35.57B+0.8% | $35.64B+2.0% | $35.63B+0.9% | $35.64B+6.7% | $35.29B+5.6% | ||
| $136.46B+0.2% | $133.96B-0.9% | $133.9B-6.6% | $137.18B-3.4% | $136.17B-8.5% | ||
| $0-100% | $2.5B— | $3.79B-69.8% | $5.56B-55.9% | $1.59B+53,000% | ||
| $0— | $2.5B— | $3.79B— | —— | —— | ||
| $42.1B+15.6% | $43.29B+11.7% | $39.39B-8.5% | $39.77B-5.1% | $36.4B-12.3% | ||
| $18M0.0% | $18M0.0% | $18M0.0% | $18M0.0% | $18M0.0% | ||
| -$17.87B-87.6% | -$15.49B-96.1% | -$14.23B-187% | -$11.5B-205% | -$9.53B-300% | ||
| -$6.66B-569% | -$3.27B-198% | -$2.64B-144% | -$183M-103% | $1.42B-82.3% | ||
| $136.46B+0.2% | $133.96B-0.9% | $133.9B-6.6% | $137.18B-3.4% | $136.17B-8.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are AbbVie's total assets?
- AbbVie (ABBV) holds $136.46B in total assets, up 0.2% year over year.
- How much cash does AbbVie have?
- AbbVie holds $9.4B in cash and equivalents.
- Can AbbVie cover its short-term obligations?
- Its current ratio is 0.80 — current liabilities exceed current assets.
- Where does AbbVie's balance sheet data come from?
- Every line is extracted from AbbVie's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
